All Articles

MASLD epidemiology, natural history and diagnosis

Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/MAFLD/MASLD)

MASLD or MAFLD: fatty liver by any name will pose the same challenge

Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence

From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management

NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease

A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Is liver fibrosis a risk factor for gynecological cancers?

The bidirectional relationship between fatty liver disease and COVID-19

MAFLD under the lens: the role of gut microbiota

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Colorectal adenomas and MAFLD: a cross-sectional study in a Hispanic screening cohort

MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?

What should we advise MAFLD patients to eat and drink?